Heart disease in thalassemia intermedia: a review of the underlying pathophysiology

Area of Science:

• Cardiology
• Hematology
• Genetics

Background:

• Beta-thalassemia encompasses a spectrum of conditions, from severe transfusion-dependent thalassemia major to milder, transfusion-independent thalassemia intermedia.
• Heart disease is a primary cause of mortality and morbidity in beta-thalassemia patients.
• Thalassemia intermedia presents unique cardiac challenges due to chronic hypoxia and vascular alterations.

Purpose of the Study:

• To elucidate the primary determinants of cardiac disease in thalassemia intermedia.
• To understand the compensatory mechanisms and vascular changes contributing to cardiac burden.
• To describe the clinical manifestations of right and left heart involvement in this patient population.

Main Methods:

• Review of existing literature on cardiac complications in beta-thalassemia intermedia.
• Analysis of pathophysiological mechanisms including hypoxia, compensatory reactions, and vascular remodeling.
• Correlation of clinical findings with cardiac structure and function.

Main Results:

• Cardiac disease in thalassemia intermedia is driven by high-output states from hypoxia and increased pulmonary vascular resistance/systemic vascular stiffness.
• Right heart involvement, leading to pulmonary hypertension and heart failure, is clinically dominant.
• Left ventricular function is typically preserved but can decompensate under increased workload, with valvular abnormalities and iron overload as contributing factors.

Conclusions:

• Cardiac pathophysiology in thalassemia intermedia involves complex interactions between hypoxia-induced high-output states and vascular stiffening.
• Right heart failure is the predominant clinical outcome, necessitating careful monitoring and management.
• While left ventricular systolic function is often maintained, it remains vulnerable to decompensation, highlighting the multifaceted cardiac impact of this condition.